In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
Adverse reactions attributed to entire drug class 'Non-steroidal anti-inflammatory (NSAID)'
Please login to view adverse reactions.
Anaphylactoid reactions / anaphylaxis (includes anaphylactic shock)
- (2015): Jares EJ+, J Allergy Clin Immunol Pract 3(5), 78058%
Angioedema (formerly named angioneurotic edema)
- (2017): Dona I+, Allergy 72(9), 1346
- (2014): Dona I+, J Investig Allergol Clin Immunol 24(3), 143
Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))
- (2021): James J+, Curr Drug Saf Oct, Online ahead of print
DRESS syndrome (Drug-induced hypersensitivity syndrome)
- (2017): Matta JM+, An Bras Dermatol 92(1), 30 [REVIEW] (passim)
- (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 539%
Fixed eruption / fixed drug eruption
- (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5316%
- (2014): Dona I+, J Investig Allergol Clin Immunol 24(3), 143 [REVIEW]
Lupus erythematosus (subacute cutaneous lupus erythematosus (SCLE))
- (2012): Dalle Vedove C+, J Dtsch Dermatol Ges 10(12), 889 [REVIEW]
- (2017): Lugovic-Mihic L+, Acta Clin Croat 56(2), 277 [REVIEW]
- (2016): Del Vecchio L+, Expert Opin Drug Saf May, Epub ahead of print [REVIEW]
- (2016): Zuba EB+, Acta Dermatovenerol Croat 24(1), 55 [REVIEW]
- (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN)
- (2022): Shao QH+, Front Pediatr May (e-Collection) (pharmacovigilance)
- (2011): Barvaliya M+, J Postgrad Med 57(2), 11522%
- (2011): Ferrandiz-Pulido C+, Med Clin (Barc) 136(13), 583
Toxic epidermal necrolysis (Lyell's syndrome)
- (2011): Barvaliya M+, J Postgrad Med 57(2), 11522%
- (2011): Ferrandiz-Pulido C+, Med Clin (Barc) 136(13), 583
- (2023): Miniello A+, Endocr Metab Immune Disord Drug Targets Sep, Online ahead of print [REVIEW]
- (2017): Dona I+, Allergy 72(9), 1346
- (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5327%
- (2014): Dona I+, J Investig Allergol Clin Immunol 24(3), 143
- (2018): Wongrakpanich S+, Aging Dis 9(1), 143 [REVIEW]
- (2017): Varga Z+, Cureus 9(4), e1144 [REVIEW]
- (2017): Varga Z+, Cureus 9(4), e1144 [REVIEW]
- (2015): Richette P+, Expert Opin Drug Saf 14(8), 1259 [REVIEW]
- (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
- (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
- (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
- (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
- (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
- (2015): Koffeman AR+, Scand J Prim Health Care 33(3), 1638%
Dyspepsia / functional dyspepsia (indigestion) (see also gastroparesis)
- (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]
- (2015): Koffeman AR+, Scand J Prim Health Care 33(3)_, 16334%
- (2022): Abdi S+, Gastroenterol Hepatol Bed Bench 15(3), 219-224 [REVIEW]
- (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]
Gastrointestinal adverse reaction
- (2021): McEvoy L+, Front Pharmacol Jun (e-Collection) [REVIEW]
- (2018): Chi TY+, Medicine (Baltimore) 97(18), e0665
- (2018): Wongrakpanich S+, Aging Dis 9(1), 143 [REVIEW]
- (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]
- (2016): Cardile S+, World J Gastroenterol 22(5), 1877
- (2016): Venerito M+, Pharmaceuticals (Basel) 3(7), 2225 [REVIEW]
Gastrointestinal perforation / perforated colon / gastric perforation
- (2017): Yang M+, Curr Med Res Opin 33(6), 973 [REVIEW]
- (2017): Chinese Rheumatism Data Center, Zhonghua Nei Ke Za Zhi (Chinese) 56(1), 81
Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)
- (2021): Kong X+, Br J Clin Pharmacol May, Online ahead of print [REVIEW]
- (2017): Eccleston C+, Cochrane Database Syst Rev 8, CD012537 [REVIEW]
Peptic ulceration (includes duodenal ulcer, esophageal ulcer)
- (2024): Islam H+, Discov Med 36(188), 1789-1799 [REVIEW]
- (2013): Sinha M+, Mediators Inflamm Mar, Epub [REVIEW]
Nephrotoxicity / kidney injury / acute kidney injury (AKI) / drug-induced kidney injury
- (2023): Dobrek L, Life (Basel) 13(2), 325 [REVIEW]
- (2023): Karimzadeh I+, Crit Care 27(1), 435 [REVIEW]
- (2023): Yousif ZK+, Kidney Int Rep 8(11), 2333-2344 (association)
- (2018): Wongrakpanich S+, Aging Dis 9(1), 143 [REVIEW]
- (2016): Vuckovic S+, Curr Med Chem 23(19), 1953
- (2015): Jung JH+, BMC Res Notes 8(1), 793
- (2015): Richette P+, Expert Opin Drug Saf 14(8), 1259 [REVIEW]
- (2015): Koffeman AR+, Scand J Prim Health Care 33(3), 1638%
Rhinitis / rhinosinusitis (see also sinusitis)
- (2022): Alromaih S+, Ear Nose Throat J Nov, Online ahead of print [REVIEW]
Adverse effects / adverse reactions
- (2022): Ziesenitz VC+, Paediatr Drugs Sep, Online ahead of print [REVIEW]
- (2016): Gerosa M+, Expert Opin Pharmacother 17(11), 1539 [REVIEW] (in pregnancy)
- (2016): Walters KM+, Immunol Allergy Clin North Am 36(4), 625 [REVIEW]
- (2016): Wong YJ, Evid Based Dent 17(3), 833–44% [REVIEW]
- (2015): Drago F+, Int J Clin Pharm 37(5), 739 (cutaneous)
- (2015): Richette P+, Expert Opin Drug Saf 14(8), 1259 [REVIEW] (gastrointestinal)
- (2015): Tian XY+, Arch Dermatol Res 307(9), 82919% (cutaneous)
- (2014): Carter GT+, Phys Med Rehabil Clin N Am 25(2), 457 [REVIEW]
